• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液凝固因子XIII在纤维蛋白溶解和血栓形成中的作用。

The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.

作者信息

Muszbek L, Bagoly Z, Bereczky Z, Katona E

机构信息

Clinical Research Center, Medical and Health Science Center, University of Debrecen, 98 Nagyerdei krt., P.O. Box 40, 4012 Debrecen, Hungary.

出版信息

Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):190-205. doi: 10.2174/187152508784871990.

DOI:10.2174/187152508784871990
PMID:18673233
Abstract

It has been known for a long time that blood coagulation factor XIII (FXIII) is essential for maintaining haemostasis, its deficiency leads to severe bleeding complication. Biochemical studies have revealed that FXIII is a key regulator of fibrinolysis and, in addition to its role in haemostasis, it has also been implicated in the pathology of arterial and venous thrombosis. Most recently, the polymorphisms in the FXIII subunit genes and their influence on the risk of thrombotic diseases have stirred a lot of interest. This review, besides including the basic biochemistry of FXIII, mainly concentrates on the biochemical and clinical aspects of the involvement of FXIII in fibrinolysis and thrombosis. Biochemical aspects: Basics on the structure and activation of plasma and cellular FXIII. The enzymological features of activated FXIII and its main substrates. The interaction of FXIIIa with fibrinogen/fibrin and with components of the fibrinolytic system. The impact of cross-linked fibrin clot formation on the fibrinolytic processes. The down-regulation of FXIIIa within the fibrin clot. FXIII polymorphisms and their biochemical consequences. Clinical Aspects: FXIII level and the risk of arterial thrombosis (coronary artery disease, peripheral artery disease, ischemic stroke). The effect of FXIII subunit polymorphisms on the risk of arterial thrombotic diseases. The interplay between FXIII polymorphisms and other factors influencing the risk of arterial thrombosis. FXIII and venous thromboembolism.

摘要

长期以来,人们都知道凝血因子 XIII(FXIII)对于维持止血至关重要,其缺乏会导致严重的出血并发症。生化研究表明,FXIII 是纤维蛋白溶解的关键调节因子,除了在止血中的作用外,它还与动脉和静脉血栓形成的病理过程有关。最近,FXIII 亚基基因的多态性及其对血栓性疾病风险的影响引起了广泛关注。本综述除了介绍 FXIII 的基本生物化学外,主要集中在 FXIII 参与纤维蛋白溶解和血栓形成的生化及临床方面。生化方面:血浆和细胞 FXIII 的结构与激活的基础知识。活化 FXIII 的酶学特性及其主要底物。FXIIIa 与纤维蛋白原/纤维蛋白以及与纤维蛋白溶解系统成分的相互作用。交联纤维蛋白凝块形成对纤维蛋白溶解过程的影响。纤维蛋白凝块内 FXIIIa 的下调。FXIII 多态性及其生化后果。临床方面:FXIII 水平与动脉血栓形成风险(冠状动脉疾病、外周动脉疾病、缺血性中风)。FXIII 亚基多态性对动脉血栓性疾病风险的影响。FXIII 多态性与其他影响动脉血栓形成风险的因素之间的相互作用。FXIII 与静脉血栓栓塞。

相似文献

1
The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.血液凝固因子XIII在纤维蛋白溶解和血栓形成中的作用。
Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):190-205. doi: 10.2174/187152508784871990.
2
Factor XIII and atherothrombotic diseases.因子 XIII 与动脉血栓性疾病。
Semin Thromb Hemost. 2010 Feb;36(1):18-33. doi: 10.1055/s-0030-1248721. Epub 2010 Apr 13.
3
Factor XIII and venous thromboembolism.因子 XIII 与静脉血栓栓塞症。
Semin Thromb Hemost. 2011 Apr;37(3):305-14. doi: 10.1055/s-0031-1273094. Epub 2011 Mar 31.
4
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.急性静脉血栓栓塞症中的因子 XIII 和纤维蛋白凝块特性。
Int J Mol Sci. 2021 Feb 5;22(4):1607. doi: 10.3390/ijms22041607.
5
FXIII polymorphisms, fibrin clot structure and thrombotic risk.凝血因子 XIII 多态性、纤维蛋白凝块结构与血栓形成风险
Biophys Chem. 2004 Dec 20;112(2-3):223-8. doi: 10.1016/j.bpc.2004.07.023.
6
Factor XIII, clot structure, thrombosis.凝血因子 XIII、血栓形成、血栓结构。
Thromb Res. 2012 Mar;129(3):382-7. doi: 10.1016/j.thromres.2011.11.040. Epub 2011 Dec 24.
7
Factor XIII deficiency.因子 XIII 缺乏症。
Haemophilia. 2008 Nov;14(6):1190-200. doi: 10.1111/j.1365-2516.2008.01857.x.
8
Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis.凝血因子XIII在缺血性卒中中的作用:促进血栓稳定和抵抗溶解的关键分子。
J Thromb Haemost. 2024 Apr;22(4):1080-1093. doi: 10.1016/j.jtha.2023.12.029. Epub 2023 Dec 30.
9
The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.凝血因子 XIII 对纤维蛋白凝块结构和纤维蛋白溶解的影响。
J Thromb Haemost. 2014 Feb;12(2):197-205. doi: 10.1111/jth.12455.
10
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.纤维蛋白原血浆水平、纤维蛋白原-455G>A 及因子 XIII A 亚单位(FXIII-A)Val34Leu 多态性在癌症相关性静脉血栓形成中的作用。
Thromb Haemost. 2011 Nov;106(5):908-13. doi: 10.1160/TH11-04-0278. Epub 2011 Sep 8.

引用本文的文献

1
Understanding blood clot mechanical stability: the role of factor XIIIa-mediated fibrin crosslinking in rupture resistance.了解血凝块的机械稳定性:因子XIIIa介导的纤维蛋白交联在抗破裂中的作用。
Res Pract Thromb Haemost. 2025 Apr 25;9(4):102871. doi: 10.1016/j.rpth.2025.102871. eCollection 2025 May.
2
Establishing the reference intervals of plasma PLG, FXII activity, and FXIII antigen in healthy adults in Guangzhou.建立广州地区健康成年人血浆纤溶酶原(PLG)、凝血因子 XII 活性及凝血因子 XIII 抗原的参考区间。
BMC Cardiovasc Disord. 2025 Jan 6;25(1):3. doi: 10.1186/s12872-024-04398-6.
3
A mathematical model of plasmin-mediated fibrinolysis of single fibrin fibers.
纤溶酶介导的单根纤维蛋白纤维纤维蛋白溶解的数学模型。
PLoS Comput Biol. 2024 Dec 20;20(12):e1012684. doi: 10.1371/journal.pcbi.1012684. eCollection 2024 Dec.
4
CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.CA9、CYFIP2和LGALS3BP——一种用于辅助胶质瘤预后评估的新型生物标志物组合
Cancers (Basel). 2024 Mar 6;16(5):1069. doi: 10.3390/cancers16051069.
5
The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors - a prospective study.所选凝血和纤溶因子对肾肿瘤患者生存的影响——一项前瞻性研究。
Arch Med Sci. 2021 Apr 8;19(4):1003-1010. doi: 10.5114/aoms/128845. eCollection 2023.
6
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.减少大型开放性血管或血管内手术中出血和输血的药物:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD013649. doi: 10.1002/14651858.CD013649.pub2.
7
Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.入院时低α2-纤溶酶抑制物抗原水平与接受静脉溶栓治疗的急性缺血性卒中患者更严重的卒中及不良预后相关。
Front Cardiovasc Med. 2022 Jul 15;9:901286. doi: 10.3389/fcvm.2022.901286. eCollection 2022.
8
Coagulation Factor XIII Val34Leu Polymorphism in the Prediction of Premature Cardiovascular Events-The Results of Two Meta-Analyses.凝血因子 XIII Val34Leu 多态性在预测心血管事件中的应用——两项荟萃分析的结果
J Clin Med. 2022 Jun 15;11(12):3454. doi: 10.3390/jcm11123454.
9
Potential Biomarkers of Acute Ischemic Stroke Etiology Revealed by Mass Spectrometry-Based Proteomic Characterization of Formalin-Fixed Paraffin-Embedded Blood Clots.基于质谱的福尔马林固定石蜡包埋血凝块蛋白质组学表征揭示的急性缺血性脑卒中病因的潜在生物标志物
Front Neurol. 2022 Apr 19;13:854846. doi: 10.3389/fneur.2022.854846. eCollection 2022.
10
Phosphorylation regulation of cardiac proteins in Babesia microti infected mice in an effort to restore heart function.努力恢复心脏功能的微小巴贝斯虫感染小鼠中心脏蛋白的磷酸化调控。
Parasit Vectors. 2022 Mar 21;15(1):98. doi: 10.1186/s13071-022-05233-7.